Since its discovery in 1921 , Insulin has emerged as a revolutionary tool in the management of diabetes. Several clinical trials have established that Insulin provides tight glycemic control and prevent long term complications in diabetics . 1 Recent research has also established that the newer Insulin analogs (e.g. Long-acting, Premix) are associated with benefits like the reduced threat of hypoglycemia , lesser weight gain , superior glycemic profile and decreased glycemic variability across the day . 2 Eli Lilly and Docplexus have organized an interactive Webinar on 30th July 2019 at 2:00 pm. In this webinar session, Dr.
Binayak Sinha , Dr. Rajiv Kovil and Dr. Usha Ayyagari will talk about “ Changing Nuances of Insulin Management ”. We invite you to submit your questions which will be answered by the speakers at the end of the session. PP-HI-IN-0167 References : 1. Shah SN.…
